3-5
2026
影响因子区间
—
平台估算
3%
2025
中国作者发文占比
40000000 IRR;600 USD
收费
期刊简介:The Patient provides a venue for scientifically rigorous, timely, and relevant research to promote the development, evaluation and implementation of therapies, technologies, and innovations that will enhance the patient experience. It is an international forum for research that advances and/or applies qualitative or quantitative methods to promote the generation, synthesis, or interpretation of evidence.The journal has specific interest in receiving original research, reviews and commentaries related to qualitative and mixed methods research, stated-preference methods, patient reported outcomes, and shared decision making.Advances in regulatory science, patient-focused drug development, patient-centered benefit-risk and health technology assessment will also be considered.Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in The Patient may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.All manuscripts are subject to peer review by international experts.
【译文】《患者》杂志提供了一个科学严谨、及时且相关的平台,以促进治疗、技术和创新的发展、评估和实施,从而提升患者体验。它是国际论坛,致力于推进和应用定性或定量方法来促进证据的生成、综合或解释。该期刊特别关注接收有关定性混合方法研究、陈述偏好方法、患者报告结果和共同决策的原创研究、评论和述评。监管科学、以患者为中心的药物开发、以患者为中心的利益风险和健康技术评估的进展也将被考虑。文章可以附带额外的数字功能(包括动画摘要、视频摘要、幻灯片、音频幻灯片、教学视频、信息图表、播客和动画),以提高期刊内容的可见性、阅读量和教育价值。此外,《患者》杂志发表的文章可能附有通俗易懂的摘要,以帮助那些对该领域有一定了解但不是深入了解的读者理解重要的医学进展。所有稿件都将由国际专家进行同行评审。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 中科院分区 | 2区 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |